Streetbeat News

Stock Prices

FLYE

GAUZ

NVL

WAY

Several companies are set to go public this week, including Waystar Holding Corp (NASDAQ:WAY), Gauzy Ltd (NASDAQ:GAUZ), Novelis Inc (NYSE:NVL), and Fly-E Group, Inc (NASDAQ:FLYE). These IPOs will offer shares at specified price ranges and have a 180-day insider lock-up period.

Portfolio Pulse from Benzinga Insights

June 02, 2024 | 9:57 pm

BTCUSD

SHIBUSD

Shiba Inu (SHIB) has seen a 207% surge in token burns, with 4,796,486 SHIB tokens burned in the last several hours. Despite a market downturn and low trading activity, the community hopes this will lead to a price recovery. SHIB's price has declined 2.18% to $0.00002473. Maintaining a price above the daily SMA 50 at $0.00002454 is critical for sustaining upward momentum.

Portfolio Pulse from Bibhu Pattnaik

June 02, 2024 | 7:41 pm

AFMD

Affimed announced that in a study of 17 EGFR wild-type NSCLC patients who failed chemotherapy and PD-1/PD-L1 treatments, AFM24 plus Atezolizumab achieved 4 objective responses. Three of these responses were ongoing for more than 7 months, and the progression-free survival was 5.9 months.

Portfolio Pulse from Charles Gross

June 02, 2024 | 6:43 pm

KPTI

Karyopharm presented updated exploratory subgroup analyses from the SIENDO study on advanced or recurrent TP53 wild-type endometrial cancer at ASCO 2024.

Portfolio Pulse from Charles Gross

June 02, 2024 | 6:37 pm

MRUS

Merus N.V. (NASDAQ:MRUS) presented updated interim clinical data on MCLA-145 monotherapy and its combination with pembrolizumab at the 2024 ASCO Annual Meeting. The data was showcased in Chicago from May 31 to June 4, 2024.

Portfolio Pulse from Charles Gross

June 02, 2024 | 6:28 pm

AZN

AstraZeneca announced that its drug Tagrisso significantly reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer compared to placebo in the LAURA Phase III trial. The results will be presented at the 2024 ASCO Annual Meeting and published in The New England Journal of Medicine.

Portfolio Pulse from Charles Gross

June 02, 2024 | 6:25 pm

A

CELH

CRM

DKNG

HRL

IOT

MDB

NOW

NTNX

SNOW

The article highlights the ten large-cap stocks that were the worst performers last week, including MongoDB, Nutanix, DraftKings, Salesforce, Samsara, Celsius Holdings, Agilent Technologies, Snowflake, ServiceNow, and Hormel Foods. The declines were driven by weak guidance, earnings results, tax hikes, and other factors.

Portfolio Pulse from Lekha Gupta

June 02, 2024 | 3:12 pm

BNTX

GMAB

Genmab A/S and BioNTech SE announced promising Phase 2 trial data for their investigational bispecific antibody acasunlimab in combination with pembrolizumab, showing a 12-month overall survival rate of 69% in patients with previously treated metastatic non-small cell lung cancer.

Portfolio Pulse from Charles Gross

June 02, 2024 | 3:02 pm

BBY

BIRK

BURL

CAVA

DKS

HPQ

MRO

NIO

ONON

RL

Ten stocks, including NIO and Best Buy, were the best performers last week. Key drivers included strong earnings reports, raised guidance, and analyst upgrades.

Portfolio Pulse from Lekha Gupta

June 02, 2024 | 2:57 pm

SPY

USO

OPEC+ has agreed to extend all production curbs into 2025 in an effort to boost oil prices, as reported by The Wall Street Journal.

Portfolio Pulse from Charles Gross

June 02, 2024 | 2:54 pm